On Thursday Oct. 24, 2024, Ark Invest, led by Cathie Wood, sold 85,456 Tesla shares valued at $22.22 million amid the stock's ...

West Pharmaceutical Services reported Q3 adjusted EPS of $1.85, beating estimates, with $746.9 million in sales. Updated 2024 ...

Evercore ISI analyst Liisa Bayko maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) today and set a price target ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

The pharma market shows promise as gene therapy gains momentum through rapid advancements that address complex diseases and ...

Another notable valuation metric for BMY is its P/B ratio of 6.19. The P/B is a method of comparing a stock's market value to its book value, which is defined as total assets minus total liabilities.

Boston has become world-famous for its booming biotech industry. Over the past 20 years, the city has been buzzing with groundbreaking discoveries, cutting-edge research, and influential biotech ...

Wells Fargo analyst Mohit Bansal has maintained their bullish stance on VRTX stock, giving a Buy rating yesterday. Mohit Bansal has given his ...

Vertex Pharmaceuticals (VRTX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at ...

In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $478.09, denoting a -1.02% change from the preceding trading day.

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.26% of ...

Indian origin. The top 30 firms have seen an increase of 89% in the overall representation of Indian-origin leaders across ...